These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16988526)

  • 21. [GlaxoSmithKline again lowers prices of drugs for HIV/AIDS and malaria].
    Krankenpfl J; 2002; 40(7-9):222-3. PubMed ID: 12514863
    [No Abstract]   [Full Text] [Related]  

  • 22. AIDS watch. Cheaper ART.
    Passi GR
    Indian Pediatr; 2001 Sep; 38(9):1072. PubMed ID: 11806344
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug makers to cut prices for developing countries.
    AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapies. The high cost of poverty.
    Cohen J
    Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
    [No Abstract]   [Full Text] [Related]  

  • 25. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11702763
    [No Abstract]   [Full Text] [Related]  

  • 26. ADAP. Group presses for price concessions on AIDS drugs.
    AIDS Policy Law; 2003 Jun; 18(12):5. PubMed ID: 12846185
    [No Abstract]   [Full Text] [Related]  

  • 27. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 28. Twenty-five years in the fight against AIDS: what have we learned?
    Proj Inf Perspect; 2006 Oct; (42):1-3. PubMed ID: 17162804
    [No Abstract]   [Full Text] [Related]  

  • 29. World Bank report examines India's approach to tackling AIDS.
    Kumar S
    BMJ; 2004 Aug; 329(7464):476. PubMed ID: 15331466
    [No Abstract]   [Full Text] [Related]  

  • 30. Low prices for HIV drugs are only one step forward.
    West PA
    BMJ; 2004 Feb; 328(7435):349-50. PubMed ID: 14764512
    [No Abstract]   [Full Text] [Related]  

  • 31. Big five to cut cost of AIDS drugs.
    S Afr Med J; 2000 Jun; 90(6):582-3. PubMed ID: 10918884
    [No Abstract]   [Full Text] [Related]  

  • 32. 3 by 5 initiative: treating 3 million by 2005.
    East Mediterr Health J; 2002 Nov; 8(6):835-7. PubMed ID: 15568463
    [No Abstract]   [Full Text] [Related]  

  • 33. AIDS activists decry steady hikes in HIV drug prices.
    AIDS Policy Law; 2005 Jul; 20(14):1, 4. PubMed ID: 16110523
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV/AIDS medicines pricing report. Setting objectives: is there a political will?
    Pérez-Casas C
    BETA; 2001; 13(4):17-21. PubMed ID: 11693076
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
    James JS
    AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embarrassed firms slash prices for AIDs drugs.
    Boseley S
    N Z Med J; 2001 Oct; 114(1141):440. PubMed ID: 11700768
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinton-brokered AIDS drug-price agreement to benefit millions.
    AIDS Policy Law; 2004 Apr; 19(8):1, 4. PubMed ID: 15146825
    [No Abstract]   [Full Text] [Related]  

  • 38. Next steps on ART.
    Gonsalves G
    Nat Med; 2002 Jul; 8(7):644. PubMed ID: 12091884
    [No Abstract]   [Full Text] [Related]  

  • 39. India's national AIDS plan.
    Br J Addict; 1992 Sep; 87(9):1357. PubMed ID: 1392559
    [No Abstract]   [Full Text] [Related]  

  • 40. Access to affordable drugs hinges on competition. Study notes lowest prices in India, South Africa.
    AIDS Alert; 2004 Nov; 19(11):129-30. PubMed ID: 15562531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.